NAMSW
NewAmsterdam Pharma Company N.V. Warrant
stockNASDAQWarrant
EODOct 16, 2026 4:00:00 PM EDT
8.82USD-41.744%(-6.32)145
NAMSW Financials
In Q2 FY 2026 (ended ), NewAmsterdam Pharma Company N.V. Warrant (NAMSW) reported revenue of $3.7M, net income of −$64.14M, operating cash flow of −$39.21M, and assets of $704.45M.
Loading financial flows…